ir versartis.com

Investor Overview - Versartis

The Investor Relations website contains information about Versartis business for stockholders, potential investors, and financial analysts.
traffic

OVERVIEW

This web site ir.versartis.com currently has an average traffic classification of zero (the lower the more users). We have scanned twenty pages inside the site ir.versartis.com and found eight websites interfacing with ir.versartis.com. There is two mass web sites linked to this website.
Pages Crawled
20
Links to this site
8
Social Links
2

IR.VERSARTIS.COM RANKINGS

This web site ir.versartis.com has seen alternating levels of traffic in the past the year.
Traffic for ir.versartis.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.versartis.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.versartis.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

Versartis, Inc.

VRS-317 is a novel, long-acting, recombinant human growth hormone, for the treatment of pediatric growth hormone deficiency. The Company has recently initiated a Phase 3 clinical study of VRS-317 in pediatric growth hormone deficient patients. New compounds developed using the XTEN technology are expected to provide improvement in outcomes such as enhanced efficacy, fewer side effects, improved patient adherence and convenience, and enhanced stability.

WHAT DOES IR.VERSARTIS.COM LOOK LIKE?

Desktop Screenshot of ir.versartis.com Mobile Screenshot of ir.versartis.com Tablet Screenshot of ir.versartis.com

IR.VERSARTIS.COM HOST

Our parsers discovered that a lone root page on ir.versartis.com took one hundred and ninety-eight milliseconds to come up. We could not find a SSL certificate, so in conclusion we consider ir.versartis.com not secure.
Load time
0.198 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19

SERVER OS AND ENCODING

I revealed that this website is employing the Microsoft-IIS/6.0 os.

PAGE TITLE

Investor Overview - Versartis

DESCRIPTION

The Investor Relations website contains information about Versartis business for stockholders, potential investors, and financial analysts.

CONTENT

This web site ir.versartis.com has the following in the web page, "is an endocrine-focused biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders." We noticed that the website also stated " Versartis was founded in December 2008 and is headquartered in Menlo Park, California, USA." It also said " 400 PM ET on Aug 17, 2015. Delayed at least 20 minutes. Versartis to Host Investor Symposium Featuring Global Opinion Leaders in Pediatric Human Growth Hormone Deficiency. View all press releases ."

SEEK SIMILAR WEBSITES

Internationale Suche von Firmen, Produkten und b2b-Dienstleistungen EUROPAGES

Finden, wählen und kontaktieren Sie die Unternehmen. Wie die Millionen professionnellen Nutzer, die EUROPAGES jeden Monat besuchen. Entdecken Sie EUROPAGES und seine Geschäftsbereiche. Maschinenbau und Industrie - Ausrüstungen. Fenster und türen und blendrahmen. Restaurants, Feinkosthändler, Lieferservice. Reinigungs- und Pflegemittel für Industrie.

Movement Republic

Say Hello 0488 888 328. An Innovative Movement Facility coming soon to Pyrmont. We are determined to change the current conversation about health, fitness and wellbeing. Be the first to find out more.

web105 server100.eroserver.eu

Hier entstehen die Internet-Seiten des Parallels Confixx Benutzers. This page is autogenerated by Parallels.